MedPath

Use of Lumbar Drain to Remove Clots in Patients Admitted to the Neuro-ICU After Subarachnoid Hemorrhage.

Not Applicable
Conditions
Subarachnoid Hemorrhage.
Registration Number
NCT01886521
Lead Sponsor
Odense University Hospital
Brief Summary

Recently, a clinical trial showed that the use of lumbar drains compared to ventricular drain in patients suffering from subarachnoid hemorrhage resulted in less delayed ischemic neurological deficits but failed to show a clinical benefit after 6 months. The underlying assumption was, that the cerebrospinal fluid (CSF) obtained from lumbar drains has a higher concentration of blood than CSF from lumbar drains. The investigators decided to test this assumption. In this study, the investigators will randomize patients to either placement of a ventricular or a lumbar drain and analyze the CSF drainage on a daily basis.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
20
Inclusion Criteria
  • Patients admitted to the neuro-ICU with aneurysmal subarachnoid hemorrhage
  • In need for CSF drainage based on clinical judgment
Exclusion Criteria
  • intraventricular clots
  • intraparenchymal clots causing midline shift
  • pregnancy

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Accumulated Hb and bilirubin in CSF drainageFrom drain placement to removal, in average 10 days.
Secondary Outcome Measures
NameTimeMethod
placement of a ventriculoperitoneal shuntparticipants will be followed for the duration of hospital stay, in average 3 weeks
Lindegaard ratio (TCD) > 3the participants will be followed for the duration of hospital stay, in average 3 weeks
clinical signs of vasospasmsThe participants will be followedd for the duration of hospital stay, in average 3 weeks

Trial Locations

Locations (1)

Department of Neurosurgery, Odense University Hospital

🇩🇰

Odense, Denmark

Department of Neurosurgery, Odense University Hospital
🇩🇰Odense, Denmark

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.